Caplin Point Laboratories Ltd Quarterly Results

Gross Sales

492.96

483.1

458.96

453.22

435.5

Excise Duty

0

0

0

0

0

Net Sales

492.96

483.1

458.96

453.22

435.5

Other Operating Income

0

0

0

0

0

Other Income

31.36

20.77

18.58

17.35

17.2

Total Income

524.32

503.87

477.54

470.57

452.7

Total Expenditure

330.68

318.44

307.15

307.99

293.22

PBIDT

193.64

185.43

170.39

162.58

159.48

Interest

0.18

0.21

0.05

0.15

0.17

PBDT

193.46

185.22

170.34

162.43

159.31

Depreciation

16.2

16.76

15.96

16.4

13.9

Minority Interest Before NP

0

0

0

0

0

Tax

34.22

32.46

29.38

20.57

26.01

Deferred Tax

2.97

5.19

0.08

4.23

-0.42

Reported Profit After Tax

140.07

130.81

124.92

121.23

119.82

Minority Interest After NP

1.11

0.01

0.95

-0.36

2.62

Net Profit after Minority Interest

138.96

130.8

123.97

121.59

117.2

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

138.96

130.8

123.97

121.59

117.2

EPS (Unit Curr.)

18.28

17.22

16.32

16.01

15.44

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

125

0

0

Equity

15.2

15.2

15.2

15.19

15.19

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

39.28

38.38

37.12

35.87

36.61

PBDTM(%)

39.24

38.33

37.11

35.83

36.58

PATM(%)

28.41

27.07

27.21

26.74

27.51